Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vasayo was a wellness and nutraceutical company that specialized in the development of nutritional supplements using advanced delivery systems. The company's core value proposition centered on its proprietary liposomal delivery technology, designed to increase the bioavailability and absorption of nutrients compared to traditional supplements. Its product line included solutions for cognitive health, sleep support, weight management, and daily nutrition. Founded in 2016 by Dallin Larsen, the company operated via a multi-level marketing (MLM) business model and expanded into several international markets. In early 2023, Vasayo announced it was winding down its operations, with its leadership and assets subsequently transitioning to a new entity known as Three International.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vasayo.